Christopher Lock
Stanford University · 47 works · 5,962 citations · h-index 22
Top works
- Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis
- THE INFLUENCE OF THE PROINFLAMMATORY CYTOKINE, OSTEOPONTIN, ON AUTOIMMUNE DEMYELINATING DISEASE
- The Influence of the Proinflammatory Cytokine, Osteopontin, on Autoimmune Demyelinating Disease
- Gene microarray identification of redox and mitochondrial elements that control resistance or sensitivity to apoptosis
- Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM
- Inhibitory role for GABA in autoimmune inflammation
- Analysis of HLA-DR glycoproteins by DNA-mediated gene transfer. Definition of DR2 beta gene products and antigen presentation to T cell clones from leprosy patients.
- MHC class II sequences of an HLA-DR2 narcoleptic
- Expression of HLA-DR4 and human CD4 transgenes in mice determines the variable region beta-chain T-cell repertoire and mediates an HLA-DR-restricted immune response.
- Minimum structural requirements for peptide presentation by major histocompatibility complex class II molecules: implications in induction of autoimmunity.
- Immune Factors in Narcolepsy
- Antigen Recognition and Peptide‐Mediated Immunotherapy in Autoimmune Disease
- The role of TNFα and lymphotoxin in demyelinating disease
- Janus-like opposing roles of CD47 in autoimmune brain inflammation in humans and mice
- The specificity of the antibody response in multiple sclerosis
- Narcolepsy and immunity.
- Prevention of insulin-dependent diabetes mellitus in nonobese diabetic mice by immunogenic but not by tolerated peptides.
- Emerging Cerebrospinal Fluid Biomarkers of Disease Activity and Progression in Multiple Sclerosis
- Selegiline in Narcolepsy
- Response to Comment on "The Influence of the Proinflammatory Cytokine, Osteopontin, on Autoimmune Demyelinating Disease"